Eitan Burstein, MD
Glaucoma Specialist · Danbury, CTNPI 1558621656
Payments from drug & device makers
Across 114 payments — averaging $86.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch Health US, LLC$5K
- AbbVie$1K
- Alcon$848
- Carl Zeiss Meditec USA, Inc.$739
- Bausch & Lomb Americas Inc.$580
- Glaukos Corporation$447
- plus $1K from 18 others
Across 11 payments — averaging $172.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Travel & lodging$65813%
- Food & beverage$4,55387%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch Health US, LLC | 1 | $4,600 |
| AbbVie(2 entities) | 41 | $1,307 |
| Alcon | 16 | $848 |
| Carl Zeiss Meditec USA, Inc. | 3 | $739 |
| Bausch & Lomb Americas Inc. | 16 | $580 |
| Glaukos Corporation | 4 | $447 |
| Nova Eye, Inc. | 1 | $273 |
| Sight Sciences, Inc. | 5 | $174 |
| Rayner Intraocular Lenses Limited | 4 | $165 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $150 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $149 |
| Novartis | 4 | $67 |
| Halozyme Inc | 2 | $51 |
| Boston Scientific | 2 | $39 |
| Harrow Eye, LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Lombart Brothers, Inc. | 1 | $29 |
| Aerie Pharmaceuticals, Inc. | 1 | $23 |
| Thea Pharma Inc. | 1 | $20 |
| NEW World Medical,inc. | 2 | $20 |
| Oyster Point Pharma, Inc. | 1 | $19 |
| Eyepoint US, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS HD-OCT$658
- IOLMaster 700$658
- VERACITY SURGICAL$658
- VisuMax$658
- XEN GLAUCOMA TREATMENT SYSTEM$411
- STELLARIS$306
- Radius XR$303
- Tecnis IOL$300
- XEN$237
- PanOptix$196
- CATALYS SYSTEM$150
- Voyager DSLT$149
- Hydrus Microstent$149
- Rocklatan$140
- ENVISTA$125
- CRYSTALENS$125
- TORIC$125
- RayOne EMV$125
- RayOne Spheric$125
- RayOne Aspheric$125
How this compares
Too few glaucoma specialist providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 197 | $110,844 |
| RocklatanNetarsudil Mesylat/Latanoprost | 92 | $60,159 |
| RestasisCyclosporine | 28 | $35,656 |
| VyzultaLatanoprostene Bunod | 66 | $31,199 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 79 | $23,857 |
| RhopressaNetarsudil Mesylate | 40 | $21,980 |
| Prednisolone Acetate | 629 | $19,291 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 75 | $11,345 |
| Brimonidine Tartrate | 134 | $9,343 |
| Timolol Maleate | 351 | $8,769 |
| CombiganBrimonidine Tartrate/Timolol | 22 | $8,417 |
| Latanoprost | 774 | $7,806 |
| Bromfenac Sodium | 34 | $7,475 |
| Travoprost | 45 | $5,215 |
| TafluprostTafluprost/Pf | 15 | $4,829 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan | $1,307 | $154,916247 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $23 | $82,138132 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $580 | $31,19966 claims |
| AlconSimbrinza | $848 | $23,85779 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few glaucoma specialist providers in Connecticuton file to place this against a meaningful peer group, so we don't.
Other glaucoma specialist in Danbury
- Bruce AltmanDanbury$5K
- Lindsay DavisWest Haven$3K
- Peter BrandenWaterbury$1K
- Stanley HershWaterbury$71
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.